1Schnitzer T, Bone HG, Crepaldi G, et al. Therapeutic equivalence of alendronate 70mg once-weekly and alendronate 10mg daily in the treatment of osteoporosis. Aging Clin Exp Res, 2000,12: 1-12.
2Orwall E,Ettinger M,Weiss S, et al. Alendronate for the treatment of osteoporosis in men. NEJM, 2000,343: 604-610.
3Hochberg M. Preventing fractures in postmenopausal women with oateoporosis. Drugs Aging, 2000,17: 317-330.
4Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab, 2000, 85: 4118-4124.
5Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with poatmenopausal osteoporosis: a randomized controlled trial. JAMA, 1999,282: 1344-1352.
6Reginster JY, Minne HW, Sorensen OH, et al. Randomized trial of the effects of fisedronate on vertebral fractures in women with established postmenopausal osteoporosis. Ostoporosis Int, 2000, 11 : 83-91.
7Andrew F,Donna M,Pamidronate:A Review of its pharmacological properties and Therapeutic effiacy in Resorptive.Bone Disease Drags,1991,41(2):289
8Shinoda H,Adamek G,Fleisch H,et al.Structure-activity relationships of various biphosphouates.Calcified Tissue International,1983,35:87
9Acconcia F, Barnes CJ, Kumar R. Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells [J]. Endocrinology,2006,147(3) :1203 - 1212.
10Koivukangas A, Juukkanen J, Harmuniemi R, et al. Effects of longterm administration of clodmnate on growing rat bone [J ]. Calcified Tissue International, 2001,69 (6) : 350.
